Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
JAMA|September 29, 2005
Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndromeDavid E Lanfear, Philip G Jones, Sharon Marsh, et al.PLOS Digital Health|October 31, 2025
Caregiver experiences of an integrative patient-centered digital health application for pediatric type 1 diabetes care: Findings from a pilot clinical trialShazhan Amed, Susan Pinkney, Fatema S Abdulhussein, et al.Pharmacogenomics|April 29, 2015
Pharmacogenomic assessment of Mexican and Peruvian populationsSharon Marsh, Cristi R King, Derek J Van Booven, et al.JMIR Human Factors|January 30, 2025
The Research Agenda for Perinatal Innovation and Digital Health Project: Human-Centered Approach to Multipartner Research Agenda CodevelopmentHaneen Amhaz, Sally Xuanping Chen, Amanee Elchehimi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan dispositionFloris A de Jong, Sharon Marsh, Ron H J Mathijssen, et al.Genomics|October 12, 2004
Pharmacogenomic assessment of carboxylesterases 1 and 2Sharon Marsh, Ming Xiao, Jinsheng Yu, et al.Clinical Pharmacology and Therapeutics|July 2, 2004
Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotypeAlex Sparreboom, Hans Gelderblom, Sharon Marsh, et al.Oncology Reports|April 12, 2011
The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancerJill M Kolesar, Suzanne E Dahlberg, Sharon Marsh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Irinotecan pathway genotype analysis to predict pharmacokineticsRon H J Mathijssen, Sharon Marsh, Mats O Karlsson, et al.Pharmacogenetics and Genomics|April 3, 2009
Association of thymidylate synthase variants with 5-fluorouracil cytotoxicityEric J Peters, Aldi T Kraja, Shiow J Lin, et al.Pageof 8